Press release
Enteric Disease Testing Market Analysis, Size, Share, Latest Trends, Growth, And Forecast To 2033
The new report published by The Business Research Company, titled ""Enteric Disease Testing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.As per the report, the enteric disease testing market size has grown strongly in recent years. It will grow from $4.33 billion in 2023 to $4.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The enteric disease testing market size is expected to see strong growth in the next few years. It will grow to $5.81 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp
The Increasing Cases Of Diarrhea And Hemolytic Urea Syndrome (HUS) Driving Growth In The Enteric Disease Testing Market
The increasing cases of diarrhea and hemolytic urea syndrome (HUS) are expected to propel the growth of the enteric disease testing market going forward. The major cause of diarrhea disease cases is the consumption of contaminated food and water. The disorder hemolytic urea syndrome (HUS) affects the blood and blood vessels and is most common in children with diarrhea. Diarrheal disease and HUS are among the leading causes of death in children under five. The increasing cases of diarrhea and hemolytic will need testing solutions, raising the demand for enteric disease testing solutions. For instance, according to the Centers for Disease Control and Prevention, diarrhea is the second greatest cause of mortality among children under the age of 5, 801 thousand worldwide, accounting for one out of every nine child deaths every year. Thus, the increasing incidences of enteric diseases will drive the growth of the enteric disease testing market.
Companies Opening New Food Testing Laboratories In The Enteric Disease Testing Market
The opening of new laboratories by companies for providing food-testing services is emerging as a key trend in the enteric disease testing market. Major companies operating in the enteric disease testing market are focused on opening new laboratories to provide food testing services. For instance, in June 2021, SGS Group, a Switzerland-based company that provides verification, testing, inspection, and certification services, announced the opening of NATA ISO17025 Accredited Laboratory, the latest addition to the SGS group which offers internationally recognized quality testing to the food manufacturing, retail market, and hospitality segments.
The enteric disease testing market covered in this report is segmented -
1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=6118&type=discount
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Quest Consumer Inc., Trinity Biotech plc., Abbott Laboratories, GlaxoSmithKline Plc., Sanofi India Limited., Bayer HealthCare Pharmaceuticals LLC, Fisher Scientific Inc., Bio Rad Laboratories Pvt Ltd., Alere Inc., 3M Company., ALS Limited, Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, Illumina Inc., BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.
Contents of the report:
1. Executive Summary
2. Enteric Disease Testing Market Report Structure
3. Enteric Disease Testing Market Trends And Strategies
4. Enteric Disease Testing Market - Macro Economic Scenario
5. Enteric Disease Testing Market Size And Growth
…..
27. Enteric Disease Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enteric Disease Testing Market Analysis, Size, Share, Latest Trends, Growth, And Forecast To 2033 here
News-ID: 3612805 • Views: …
More Releases from The Business research company

Palm Kernel Fatty Acids Market Size to Reach $10.41 Billion by 2029 | Growth at …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Palm Kernel Fatty Acids Industry?
In recent years, the market size for palm kernel fatty acids has shown significant growth. The market is anticipated to expand from $7.68 billion in 2024 to $8.13 billion in 2025, marking a compound annual growth rate (CAGR)…

Naphthalene Sulfonate Industry Set to Achieve $1.23 Billion Milestone by 2029 | …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Naphthalene Sulfonate Market Size 2025?
In the past years, the naphthalene sulfonate market has seen significant growth. Its size is projected to increase from $0.91 billion in 2024 to $0.96 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing…

Global Industrial Enzymes Market Size, Share, and Forecast Analysis 2025-2029
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Industrial Enzymes Market Size Forecast for 2025?
The market size of industrial enzymes has seen robust growth in the recent past. The market, standing at $7.19 billion in 2024, is projected to rise to $7.66 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.6%.…

Global Glycerol Derivatives Market Worth $21.97 Billion by 2029, Growing at 6.5% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Glycerol Derivatives Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market size of glycerol derivatives has seen robust growth in the past few years. The scale is expected to expand from $16.11 billion in 2024 to $17.1 billion in 2025, registering a compound annual growth rate (CAGR)…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…